What's driving the U.S. Medical Marijuana Market trends? United Cannabis, Canopy Growth, Aurora Cannabis, Inc., Medical Marijuana, Inc., GW Pharmaceuticals, Aphria, Inc., Tilray, Emerald Health Therapeutics

Market Study Report LLC presents an extensive report on U.S. Medical Marijuana market that offers qualitative information about prevailing trends and a detailed analysis of the growth trajectory of this industry. It also includes a study of the historical data and detailed statistics that will help determine the future scope of the industry in terms of commercialization opportunities.

U.S. Medical Marijuana Market will exceed USD 8.0 billion by 2024; as per a new research report. The U.S. Medical Marijuana Market report 2018-2024 provides a comprehensive landscape of the industry, accurate market estimates and forecast split By Application, By Route of Administration, By Distribution Channel and regions. All quantitative information is covered on a regional as well as country basis. The report provides valuable strategic insights on the U.S. Medical Marijuana, analyzing in detail industry impact forces including growth drivers, pitfalls and regulation evolution. The report also includes a detailed outlook on the U.S. Medical Marijuana segment competitive environment, diving in to the industry position of each major company along with the strategic landscape.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1251693/?utm_source=Openpr.com-SP

The U.S. medical marijuana inhalation market segment is estimated to grow at 13.4% CAGR during the forecast period. Factors such as controlled dosage rates and better absorption of medical marijuana into the body will drive the inhalation route of administration market segment. Moreover, the U.S. population prefers to inhale medical marijuana owing to its better perceiving rate with high peak concentrations.

U.S. online medical marijuana market segment is forecasted to expand at a CAGR of 13.9% during 2018-2024. Factors such as vast product portfolio, convenience, and competitive costs will boost the growth of online medical marijuana market segment. Also, online distribution channel has an effective customer service that will propel the market revenue of this segment.
The U.S. Pacific Central medical marijuana market was valued at around USD 2,085.9 million in 2017. California was the first state to legalize medical marijuana way back in 1996. Other states such as Alaska, Oregon and Washington also headed in the same pathway and got the approval for medical marijuana use in 1998. All these factors are responsible for the market growth in U.S. Pacific Central.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1251693/?utm_source=Openpr.com-SP

More than half of the U.S. states and Washington D.C. have legalized marijuana for therapeutic application. Increased number of people affected with chronic pain caused due to cancer, HIV/AIDS and neurological diseases will drive the market growth in the U.S. In addition, rigorous research and development on marijuana is also rising in the U.S., thereby opening avenues for novel products in the market.

U.S. has allowed to issue medical marijuana cards in 30 states that will enable a patient with a doctor's recommendation to obtain and possess marijuana for therapeutic use. There has been increase in the number of doctors in the U.S. recommending medical marijuana to patients as a part of their overall plan of treatment due to marijuana?s greater efficacy and usefulness, thereby boosting sales.

However, factors such as few adverse side effects of marijuana, lack of safety data, strict U.S. regulatory norms and difficulty in setting up marijuana business will act as major barriers in the growth of U.S. medical marijuana market.

Notable U.S. Medical Marijuana market players comprise of Canopy Growth, Aphria, Inc, Aurora Cannabis, Inc, GW Pharmaceuticals, mCig, Medical Marijuana, Inc, United Cannabis, Tilray, Emerald Health Therapeutics, Lexaria Corporation, Cannabis Sativa, Inc, Insys Therapeutics, Inc, Corbus Pharmaceuticals, GBSciences, Inc.

Table of Content:

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. U.S. Medical marijuana industry 360 degree synopsis, 2013 - 2024

2.1.1. Business trends

2.1.2. Application trends

2.1.3. Route of administration trends

2.1.4. Distribution channel trends

2.1.5. Regional trends

Chapter 3. U.S. Medical Marijuana Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Increasing application of marijuana for a myriad of medical conditions and symptoms

3.3.1.2. Growing demand for medical marijuana legalization in the U.S.

3.3.1.3. Rising number of R&D and clinical trial activities

3.3.2. Industry pitfalls & challenges

3.3.2.1. Few side effects might hinder the market growth

3.3.2.2. Difficulty in medical marijuana business banking

3.4. Growth potential analysis

3.4.1. By application

3.4.2. By route of administration

3.4.3. By distribution channel

3.5. Porter's analysis

3.6. Competitive landscape, 2017

3.6.1. Business overview

3.6.2. Revenue analysis

3.6.3. Product landscape

3.6.4. Strategy dashboard

3.7. PESTEL analysis

3.8. Value chain analysis

3.9. Legal Requirement for Distribution of Medical Marijuana

3.10. Regulatory Landscape

Chapter 4. U.S. Medical Marijuana Market, By Application

4.1. U.S. medical marijuana market share, by application, 2017 & 2024

4.2. Pain Management

4.2.1. Market estimates and forecast, by region, 2013 - 2024

4.2.2. Neuropathic Pain

4.2.2.1. Market estimates and forecast, by region, 2013 - 2024

4.2.3. Cancer Pain

4.2.3.1. Market estimates and forecast, by region, 2013 - 2024

For more information on this report at: https://www.marketstudyreport.com/reports/u-s-medical-marijuana-market/?utm_source=Openpr.com-SP

Related Reports: -
United States Medical Marijuana Market Report 2018
United States Medical Marijuana market competition by top manufacturers/players, with Medical Marijuana sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Cara Therapeutics, Cannabis Sativa, CannaGrow Holdings, United Cannabis, Growblox Sciences, GreenGro Technologies
https://www.marketstudyreport.com/reports/united-states-medical-marijuana-market-report-2018?utm_source=RR-SP

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog

This release was published on openPR.